FRPTMEDIUM SIGNALOPPORTUNITY10-K

FRPT delivered exceptional profitability growth with net income nearly tripling to $139.1M while expanding market penetration and maintaining strong revenue growth.

The company demonstrated strong operational leverage with operating income doubling despite modest revenue growth, indicating improved efficiency and pricing power. Market penetration expanded from 13.5M to 15.2M households, representing solid progress toward their 20M household target by 2027.

Comparing 2026-02-23 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

FRPT showed impressive financial performance with net income surging 196.5% to $139.1M while revenue grew a solid 13% to $1.1B, demonstrating strong operational leverage and margin expansion. The balance sheet strengthened with stockholders' equity increasing 14.5% and current liabilities declining 20.5%, though interest expense increased significantly to $14.1M reflecting higher debt levels. Overall, the financial picture signals a company hitting its stride with improving profitability, strong cash generation, and expanding market share in the resilient pet food sector.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+196.5%
$46.9M→$139.1M

Net income grew 196.5% — bottom-line growth signals improving overall business health.

Interest Expense
P&L
+170.7%
$5.2M→$14.1M

Interest expense surged 170.7% — significant debt increase or rising rates materially impacting earnings.

Operating Income
P&L
+99.1%
$38.0M→$75.7M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

R&D Expense
P&L
-30.9%
$1.2M→$800K

R&D spending cut 30.9% — could signal cost discipline or concerning reduction in innovation investment.

Current Liabilities
Balance Sheet
-20.5%
$98.9M→$78.6M

Current liabilities reduced — improved short-term financial position and working capital health.

Stockholders Equity
Balance Sheet
+14.5%
$1.1B→$1.2B

Equity base grew 14.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Gross Profit
P&L
+13.6%
$396.0M→$449.6M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+13%
$975.2M→$1.1B

Revenue growing 13% — solid top-line momentum, watch margins for quality of growth.

Total Assets
Balance Sheet
+12.9%
$1.6B→$1.8B

Asset base grew 12.9% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-23
PRIOR — 2025-02-20
ADDED
As of February 19, 2026, 49,057,177 shares of common stock of the registrant were outstanding.
While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.
As of December 31, 2025, our household penetration within the United States was approximately 15.2 million households.
The pet food market has historically been resilient as consumers continue to spend on their pets even during economic downturns, and we believe pet food spending in North America will increase long-term.
We believe the following trends will drive growth in our industry: Pet ownership.
+7 more — sign up free →
REMOVED
As of February 18, 2025, 48,718,620 shares of common stock of the registrant were outstanding.
As of December 31, 2024, our household penetration within the United States was approximately 13.5 million, with a target of 20 million households by 2027.
We believe pet food spending in North America will continue to increase at a similar rate as it has in the past.
The pet food market has historically been resilient as consumers continue to spend on their pets even during economic downturns.
We believe the following trends are driving growth in our industry: Pet ownership.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
IRIXHIGHIRIX demonstrated a dramatic operational turnaround with revenue surging 283% wh...
2026-04-02
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →